Annual EBIT
-$86.46 M
+$6.37 M+6.86%
December 31, 2023
Summary
- As of February 7, 2025, BDTX annual earnings before interest & taxes is -$86.46 million, with the most recent change of +$6.37 million (+6.86%) on December 31, 2023.
- During the last 3 years, BDTX annual EBIT has fallen by -$19.21 million (-28.56%).
- BDTX annual EBIT is now -1805.66% below its all-time high of -$4.54 million, reached on December 31, 2017.
Performance
BDTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$18.13 M
+$4.00 M+18.08%
September 30, 2024
Summary
- As of February 7, 2025, BDTX quarterly earnings before interest & taxes is -$18.13 million, with the most recent change of +$4.00 million (+18.08%) on September 30, 2024.
- Over the past year, BDTX quarterly EBIT has increased by +$5.88 million (+24.50%).
- BDTX quarterly EBIT is now -496.58% below its all-time high of -$3.04 million, reached on December 31, 2018.
Performance
BDTX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$81.36 M
+$5.88 M+6.74%
September 30, 2024
Summary
- As of February 7, 2025, BDTX TTM earnings before interest & taxes is -$81.36 million, with the most recent change of +$5.88 million (+6.74%) on September 30, 2024.
- Over the past year, BDTX TTM EBIT has increased by +$6.10 million (+6.97%).
- BDTX TTM EBIT is now -2577.23% below its all-time high of -$3.04 million, reached on December 31, 2018.
Performance
BDTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
BDTX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.9% | +24.5% | +7.0% |
| 3 y3 years | -28.6% | +48.7% | +34.1% |
| 5 y5 years | -871.0% | -95.6% | -130.7% |
BDTX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +31.9% | at high | +30.5% | at high | +35.9% |
| 5 y | 5-year | -145.2% | +31.9% | -83.6% | +48.7% | -130.7% | +35.9% |
| alltime | all time | -1805.7% | +31.9% | -496.6% | +48.7% | -2577.2% | +35.9% |
Black Diamond Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$18.13 M(-18.1%) | -$81.36 M(-6.7%) |
| Jun 2024 | - | -$22.13 M(+9.3%) | -$87.24 M(+2.5%) |
| Mar 2024 | - | -$20.25 M(-2.9%) | -$85.14 M(-1.5%) |
| Dec 2023 | -$86.46 M(-6.9%) | -$20.86 M(-13.1%) | -$86.46 M(-1.1%) |
| Sep 2023 | - | -$24.01 M(+19.9%) | -$87.46 M(+2.2%) |
| Jun 2023 | - | -$20.03 M(-7.1%) | -$85.57 M(-3.5%) |
| Mar 2023 | - | -$21.56 M(-1.3%) | -$88.71 M(-4.4%) |
| Dec 2022 | -$92.83 M(-26.8%) | -$21.85 M(-1.2%) | -$92.83 M(-4.4%) |
| Sep 2022 | - | -$22.12 M(-4.5%) | -$97.06 M(-12.0%) |
| Jun 2022 | - | -$23.17 M(-9.8%) | -$110.30 M(-9.5%) |
| Mar 2022 | - | -$25.68 M(-1.5%) | -$121.84 M(-4.0%) |
| Dec 2021 | -$126.87 M | -$26.08 M(-26.3%) | -$126.87 M(+2.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$35.36 M(+1.9%) | -$123.42 M(+16.5%) |
| Jun 2021 | - | -$34.72 M(+13.0%) | -$105.97 M(+23.5%) |
| Mar 2021 | - | -$30.71 M(+35.7%) | -$85.82 M(+26.2%) |
| Dec 2020 | -$67.25 M(+90.7%) | -$22.63 M(+26.3%) | -$67.99 M(+23.1%) |
| Sep 2020 | - | -$17.91 M(+22.9%) | -$55.24 M(+18.6%) |
| Jun 2020 | - | -$14.57 M(+13.1%) | -$46.59 M(+5.2%) |
| Mar 2020 | - | -$12.88 M(+30.4%) | -$44.31 M(+25.6%) |
| Dec 2019 | -$35.26 M(+296.0%) | -$9.88 M(+6.5%) | -$35.27 M(+24.0%) |
| Sep 2019 | - | -$9.27 M(-24.6%) | -$28.43 M(+48.4%) |
| Jun 2019 | - | -$12.29 M(+219.9%) | -$19.17 M(+178.6%) |
| Mar 2019 | - | -$3.84 M(+26.4%) | -$6.88 M(+126.4%) |
| Dec 2018 | -$8.90 M(+96.3%) | -$3.04 M | -$3.04 M |
| Dec 2017 | -$4.54 M | - | - |
FAQ
- What is Black Diamond Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics annual EBIT year-on-year change?
- What is Black Diamond Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics quarterly EBIT year-on-year change?
- What is Black Diamond Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics TTM EBIT year-on-year change?
What is Black Diamond Therapeutics annual earnings before interest & taxes?
The current annual EBIT of BDTX is -$86.46 M
What is the all time high annual EBIT for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high annual earnings before interest & taxes is -$4.54 M
What is Black Diamond Therapeutics annual EBIT year-on-year change?
Over the past year, BDTX annual earnings before interest & taxes has changed by +$6.37 M (+6.86%)
What is Black Diamond Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of BDTX is -$18.13 M
What is the all time high quarterly EBIT for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high quarterly earnings before interest & taxes is -$3.04 M
What is Black Diamond Therapeutics quarterly EBIT year-on-year change?
Over the past year, BDTX quarterly earnings before interest & taxes has changed by +$5.88 M (+24.50%)
What is Black Diamond Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of BDTX is -$81.36 M
What is the all time high TTM EBIT for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high TTM earnings before interest & taxes is -$3.04 M
What is Black Diamond Therapeutics TTM EBIT year-on-year change?
Over the past year, BDTX TTM earnings before interest & taxes has changed by +$6.10 M (+6.97%)